More and more evidence mounting that US will be passing the...

More and more evidence mounting that US will be passing the re-scheduling sooner rather than later with news dropping that discussions were started back in January by Congress.

US Cann ETFs clearly being bought into the expectation of news with MSOS up another 6.7% (24% in last 2 trading sessions) pushing their market cap near $1b. Still trading near flat relative to 6m ago, 50% up YoY and 82% down from all time highs in Feb-21. To see these highs tested again is inevitable with policy, fundamentals and markets showing far more positive sentiment now than ever before. MSOX also seeing exceptional trading volumes (2x leveraged MSOS) up 54% in the last trading week. Amplify (2nd largest Can ETF), showing similar movements. 1/4 of the assets held at ~250M USD.

Unfortunately MSOS is exclusive invested in US companies… so slim chance of adding liquidity to us any time soon unless a US company were to acquire.

Amplify does however invest globally. They are yet to enter the Aus market but do have indirect exposure through Aurora Cannabis who were wholly acquired by Curaleaf. Perhaps some input from the ETF management…

Would be great to see Cann ETFs diversify and de-risk themselves through utilisation of the Aus market. It’ll be evident when this does happen as we’ll see significant increase in liquidity and volatility. For me, it’s a matter of when they invest down under rather then if, can’t be a global diversified holding without tapping into Australia IMO.